Jack Resneck, MD

Title(s)Professor, Dermatology
SchoolSchool of Medicine
Phone415-353-9610
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Brown University, Providence, RIBA06/1992Public Policy
    UCSF School of Medicine, San Francisco, CAMD06/1997Medicine
    UCSF School of Medicine Dept. of Medicine06/1998Internship in Internal Medicine
    UCSF School of Medicine Dept. of Dermatology06/2001Residency in Dermatology
    UCSF Philip R. Lee Institute for Health Policy Studies06/2003Fellowship in Health Policy
    University of California, San Francisco, CA2019Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse Overview
    Dr. Resneck is the Bruce U. Wintroub Endowed Professor and Chair of the UCSF Department of Dermatology, and holds a joint appointment as an affiliated faculty member at the Philip R. Lee Institute for Health Policy Studies. In earlier roles, Dr. Resneck served as residency training director and then medical director for dermatology at UCSF.

    Dr. Resneck became president of the American Medical Association in June 2022. He is a passionate advocate for physicians and patients, a prominent spokesperson for innovation, and a champion for a more equitable health care system. Whether testifying before Congress about removing dysfunction from health care, caring for his patients at UCSF, or advocating for physician values in emerging technology, Dr. Resneck channels his leadership to improve the lives of patients and the working environment for America’s physicians to help build stronger, healthier communities.

    Dr. Resneck was elected to the American Medical Association Board of Trustees in 2014 and served as its chair from 2018 to 2019. He is a former member of the board of the American Academy of Dermatology and the former president of the California Society for Dermatology and Dermatologic Surgery. Currently, he is a member of the editorial board of the Journal of the American Academy of Dermatology and serves on the board of directors for the National Quality Forum. He is active in health services research, and his studies on patient access to care, health care delivery, telemedicine and public health have been published in prominent journals and attracted national media attention. He is a sought-after speaker and has given dozens of invited lectureships around the country.

    Dr. Resneck’s leadership is collaborative, inclusive, focused and infused with purpose. This is evident whether he is engaging the AMA’s Litigation Center to protect physicians’ free speech and fight societal discrimination against marginalized patients—or advocating on Capitol Hill for fair Medicare payment systems, improved patient access to care, lower prescription drug prices, and reduced dysfunction and burdens in health care.

    Raised in Louisiana, Dr. Resneck received his BA in public policy from Brown University and his MD from UCSF—where he also completed his internship in internal medicine, residency in dermatology and fellowship in health policy.

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Clinicians and Professional Societies COVID-19 Impact Assessment: Lessons Learned and Compelling Needs. NAM Perspect. 2021; 2021. Madara J, Miyamoto S, Farley JE, Gong M, Gorham M, Humphrey H, Irons M, Mehrotra A, Resneck J, Rushton C, Shanafelt T. PMID: 34532690; PMCID: PMC8406512.
      View in: PubMed   Mentions: 2  
    2. Insurance Acceptance, Appointment Wait Time, and Dermatologist Access Across Practice Types in the US. JAMA Dermatol. 2021 02 01; 157(2):181-188. Creadore A, Desai S, Li SJ, Lee KJ, Bui AN, Villa-Ruiz C, Lo K, Zhou G, Joyce C, Resneck JS, Seiger K, Mostaghimi A. PMID: 33439219; PMCID: PMC7807384.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    3. The 2020 annual report of DataDerm: The database of the American Academy of Dermatology. J Am Acad Dermatol. 2021 Apr; 84(4):1037-1041. Van Beek MJ, Swerlick RA, Mathes B, Hruza GJ, Resneck J, Pak HS, Kaye T, Aninos A, Agregado B, Fitzgerald M, Jacobs JP. PMID: 33316331.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Changes in Drug List Prices and Amounts Paid by Patients and Insurers. JAMA Netw Open. 2020 12 01; 3(12):e2028510. Yang EJ, Galan E, Thombley R, Lin A, Seo J, Tseng CW, Resneck JS, Bach PB, Dudley RA. PMID: 33295971; PMCID: PMC7726630.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Refocusing Medication Prior Authorization on Its Intended Purpose. JAMA. 2020 Feb 25; 323(8):703-704. Resneck JS. PMID: 32011641.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    6. Physicians Respond to Accurate, Actionable Data on Their Performance. JAMA Dermatol. 2019 Aug 01; 155(8):881-883. Resneck JS, VanBeek M. PMID: 31055595.
      View in: PubMed   Mentions:    Fields:    
    7. Dermatology Practice Consolidation Fueled by Private Equity Investment: Potential Consequences for the Specialty and Patients. JAMA Dermatol. 2018 01 01; 154(1):13-14. Resneck JS. PMID: 29164229.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    8. A risk adjustment approach to estimating the burden of skin disease in the United States. J Am Acad Dermatol. 2018 Jan; 78(1):129-140. Lim HW, Collins SAB, Resneck JS, Bolognia J, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Begolka WS, Moyano JV. PMID: 29110889.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. Contribution of health care factors to the burden of skin disease in the United States. J Am Acad Dermatol. 2017 Jun; 76(6):1151-1160.e21. Lim HW, Collins SAB, Resneck JS, Bolognia JL, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Smith Begolka W, Moyano JV. PMID: 28427793.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. The burden of skin disease in the United States. J Am Acad Dermatol. 2017 May; 76(5):958-972.e2. Lim HW, Collins SAB, Resneck JS, Bolognia JL, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Smith Begolka W, Moyano JV. PMID: 28259441.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    11. Transparency Associated With Interactions Between Industry and Physicians: Deficits in Accuracy and Consistency of Public Data Releases. JAMA Dermatol. 2016 12 01; 152(12):1303-1304. Resneck JS. PMID: 27706480.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. Choice, Transparency, Coordination, and Quality Among Direct-to-Consumer Telemedicine Websites and Apps Treating Skin Disease. JAMA Dermatol. 2016 07 01; 152(7):768-75. Resneck JS, Abrouk M, Steuer M, Tam A, Yen A, Lee I, Kovarik CL, Edison KE. PMID: 27180232.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    13. Online Advertising for Cancer Prevention: Google Ads and Tanning Beds. JAMA Dermatol. 2016 Jan; 152(1):101-2. Cidre Serrano W, Chren MM, Resneck JS, Aji NN, Pagoto S, Linos E. PMID: 26444220.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    14. Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer--Reply. JAMA Dermatol. 2015 Sep; 151(9):1037. Linos E, VanBeek M, Resneck JS. PMID: 26177163.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. A Sudden and Concerning Increase in the Use of Electronic Brachytherapy for Skin Cancer. JAMA Dermatol. 2015 Jul; 151(7):699-700. Linos E, VanBeek M, Resneck JS. PMID: 25785818.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    16. What dermatology still needs to create meaningful patient outcome measurements. JAMA Dermatol. 2015 Apr; 151(4):371-2. Resneck JS, VanBeek M. PMID: 25549325.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. The accuracy of dermatology network physician directories posted by Medicare Advantage health plans in an era of narrow networks. JAMA Dermatol. 2014 Dec; 150(12):1290-7. Resneck JS, Quiggle A, Liu M, Brewster DW. PMID: 25354035.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    18. Twitter: an opportunity for public health campaigns. Lancet. 2014 Jul 12; 384(9938):131-2. Wehner MR, Chren MM, Shive ML, Resneck JS, Pagoto S, Seidenberg AB, Linos E. PMID: 25016994.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    19. Compliance by California tanning facilities with the nation's first statewide ban on use before the age of 18 years. J Am Acad Dermatol. 2013 Dec; 69(6):883-889.e4. Grewal SK, Haas AF, Pletcher MJ, Resneck JS. PMID: 24120564.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    20. Research agenda consensus conference. J Am Acad Dermatol. 2013 Aug; 69(2):294. Lim HW, Resneck JS, Fischoff R. PMID: 23643342.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Dermatology workforce policy then and now: reflections on Dr Peyton Weary's 1979 manuscript. J Am Acad Dermatol. 2013 Feb; 68(2):338-9. Resneck JS. PMID: 23317972.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. An analysis of dermatologist migration patterns after residency training. Arch Dermatol. 2011 Sep; 147(9):1065-70. Resneck JS, Kostecki J. PMID: 21931044.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. An analysis of health system reform for dermatologists: elements and implications of the Patient Protection and Affordable Care Act. J Am Acad Dermatol. 2010 Oct; 63(4):706-15. Resneck JS. PMID: 20708300.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Shared medical appointments: will changes in health care delivery and financing promote increased use of nonphysician clinicians in dermatology patient counseling? Arch Dermatol. 2010 Apr; 146(4):434-6. Resneck JS, VanBeek M. PMID: 20404236.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Individual drug sampling does not supplant the need for head-to-head trials in dermatology. J Am Acad Dermatol. 2010 Jun; 62(6):1062-3. Resneck JS, Vanbeek M. PMID: 20172624.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Patient safety: Part I. Patient safety and the dermatologist. J Am Acad Dermatol. 2009 Aug; 61(2):179-90; quiz 191. Elston DM, Taylor JS, Coldiron B, Hood AF, Read SI, Resneck JS, Kirsner RS, Maize JC, Sullivan S, Laskas J, Hanke CW. PMID: 19615535.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. Commentary: The relative ease of obtaining a dermatologic appointment in Boston: how methods drive results. J Am Acad Dermatol. 2009 Jun; 60(6):949-50. Feldman SR, Resneck JS. PMID: 19467367.
      View in: PubMed   Mentions:    Fields:    
    28. A gender gap in the dermatology literature? Cross-sectional analysis of manuscript authorship trends in dermatology journals during 3 decades. J Am Acad Dermatol. 2009 Jan; 60(1):63-9. Feramisco JD, Leitenberger JJ, Redfern SI, Bian A, Xie XJ, Resneck JS. PMID: 19103359.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    29. Pediatric dermatology workforce shortage: perspectives from academia. J Am Acad Dermatol. 2008 Dec; 59(6):986-9. Craiglow BG, Resneck JS, Lucky AW, Sidbury R, Yan AC, Resnick SD, Antaya RJ. PMID: 18835061.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    30. The US dermatology workforce: a specialty remains in shortage. J Am Acad Dermatol. 2008 Nov; 59(5):741-5. Kimball AB, Resneck JS. PMID: 18723242.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    31. Who else is providing care in dermatology practices? Trends in the use of nonphysician clinicians. J Am Acad Dermatol. 2008 Feb; 58(2):211-6. Resneck JS, Kimball AB. PMID: 18222319.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    32. Short wait times for patients seeking cosmetic botulinum toxin appointments with dermatologists. J Am Acad Dermatol. 2007 Dec; 57(6):985-9. Resneck JS, Lipton S, Pletcher MJ. PMID: 17720277.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    33. Few Medicaid and uninsured patients are accessing dermatologists. J Am Acad Dermatol. 2006 Dec; 55(6):1084-8. Resneck JS, Isenstein A, Kimball AB. PMID: 17097404.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    34. The influence of controllable lifestyle on medical student specialty choice. Virtual Mentor. 2006 Aug 01; 8(8):529-32. Resneck JS. PMID: 23234693.
      View in: PubMed   Mentions: 3     Fields:    
    35. Even patients with changing moles face long dermatology appointment wait-times: a study of simulated patient calls to dermatologists. J Am Acad Dermatol. 2006 Jul; 55(1):54-8. Tsang MW, Resneck JS. PMID: 16781292.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    36. Dinners with Irwin: mentorship, the work force, and the future of academic dermatology. J Invest Dermatol. 2006 Mar; 126(3):529-30. Resneck JS, Kimball AB. PMID: 16482186.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Trends in malpractice premiums for dermatologists: results of a national survey. Arch Dermatol. 2006 Mar; 142(3):337-40. Resneck JS. PMID: 16549709.
      View in: PubMed   Mentions: 1     Fields:    
    38. Challenges facing academic dermatology: survey data on the faculty workforce. J Am Acad Dermatol. 2006 Feb; 54(2):211-6. Resneck JS, Tierney EP, Kimball AB. PMID: 16443049.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    39. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA. 2004 Dec 01; 292(21):2614-21. Resneck JS, Van Beek M, Furmanski L, Oyugi J, LeBoit PE, Katabira E, Kambugu F, Maurer T, Berger T, Pletcher MJ, Machtinger EL. PMID: 15572719.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    40. Generational differences in practice patterns of dermatologists in the United States: implications for workforce planning. Arch Dermatol. 2004 Dec; 140(12):1477-82. Jacobson CC, Resneck JS, Kimball AB. PMID: 15611425.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    41. How health policy and health services researchers are compensated: analysis of a nationwide salary survey. Med Care Res Rev. 2004 Sep; 61(3):392-408. Resneck J, Luft H. PMID: 15358973.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. The dermatology workforce shortage. J Am Acad Dermatol. 2004 Jan; 50(1):50-4. Resneck J, Kimball AB. PMID: 14699364.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    43. Medicare, Medicaid, and access to dermatologists: the effect of patient insurance on appointment access and wait times. J Am Acad Dermatol. 2004 Jan; 50(1):85-92. Resneck J, Pletcher MJ, Lozano N. PMID: 14699371.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    44. Ducking stray "magic bullets": a Melan-A alert. Am J Dermatopathol. 2003 Apr; 25(2):162-5. Maize JC, Resneck JS, Shapiro PE, McCalmont TH, LeBoit PE. PMID: 12652201.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    45. Drug samples: friend or foe? J Drugs Dermatol. 2002 Sep; 1(2):124. Resneck J. PMID: 12847734.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Too few or too many dermatologists? Difficulties in assessing optimal workforce size. Arch Dermatol. 2001 Oct; 137(10):1295-301. Resneck J. PMID: 11594852.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    Jack's Networks
    Concepts (183)
    Derived automatically from this person's publications.
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _